Search:
 

News & Comment

Woundcare group on the prowl

Advanced Medical Solutions is considering ‘suitable acquisitions’ after hoisting annual profits from £27,000 to nearly £600,000. Read

Woundcare group signals profitability

Advanced Medical Solutions says it is speeding 'a move to profitability' and considering possible acquisitions. Read

Advanced Medical in Ulster deal

Wound care specialist Advanced Medical Solutions (AMS) is to supply its products to Northern Ireland's National Health service hospitals. Read

Profit promise from AMS

Don Evans, chief executive of Advanced Medical Solutions, says business partners have shown 'phenomenal interest' in its acquisition of MedLogic, while two new development deals should help AMS reach breakeven this year. William Davidson reports. Read

AMS heads towards profit

Wound care products developer Advance Medical Solutions is moving from techMARK to Aim at the end of this month and should break even by year-end, thanks to its recent acquisition of US group MedLogic, writes William Davidson. Read

Advanced Medical's silver solution

TechMARK-listed wound care company Advanced Medical Solutions (AMS) has signed a licensing deal that will see it incorporate silver fibres into its wound dressings. This is the way the world of wound care dressings is heading. William Davidson reports. Read

Recommendations

Silver lining at AMS
BUY 06/10/2008

Wound treatment developer Advanced Medical Solutions (AMS) has seen its share price more than triple in three years – but new investors shouldn’t think they’ve missed the boat as there should be plenty more to come. Oliver Haill reports Read
Companies: AMS   

Advanced Medical Solutions
NO RECOMMENDATION 18/04/2002

Read
Companies: AMS   

Advanced Medical Solutions
NO RECOMMENDATION 07/01/2002

Read
Companies: AMS   

Advanced Medical Solutions
NO RECOMMENDATION 03/09/2001

Read
Companies: AMS   

Sector Articles

Finance houses may be struggling compared with the 1980s and 1990s, but there is no lack of activity on Aim. While the final demerger of one of the most traded companies, Chorion, into two divisions was grabbing the headlines, 13 new issues (five from the Full List) once more underlined the junior market's attraction to investors and institutions alike. Read